Fabiola Cineas

Business Editor

@fabiolacineas
Business

This One Thing Motivates Employees More Than Money

Employers need to step their game up in this category.

trump, syria
News

Repeat After Me: Donald Trump Is Racist.

I’m done letting politicians and the media sidestep the obvious.

Business

Philly Tech Companies Benefitted Big From State Tax Credits in 2017

Here’s how much they were awarded.

Business

Comcast Scion Now At the Helm of Philadelphia Esports Team

Tucker Roberts will lead Fusion through its first season this year.

Business

Comcast Is Now Taking Applications for Its New Startup Accelerator

Techstars will run the program at the telecom giant’s new tech skyscraper this year.

Business

Why Aren’t Philadelphians Aiming for the Corner Office?

A new LinkedIn study sheds some light on our career goals for 2018.

Business

PHOTOS: Inside Turn5’s Brand New Headquarters

A bowling alley is just one feature of the e-commerce company’s new digs.

Business

Penn Medicine and Princeton HealthCare System Officially Merge

This is Penn’s first major expansion into New Jersey.

Business

Philly Auto Show Director Kevin Mazzucola

Here’s how he plans a nine-day car-filled party for about 250,000 people.

Business

Comcast Buys Out Philly’s Only Black-Owned Cable TV Provider

Here’s why Wilco Electronic Systems says it is pleased with the deal.

Business

Sears to Close More Philadelphia Stores This Spring

The retailer will shut down 103 stores total nationwide.

Business

Stephen Tang on His Decade as Science Center CEO

He opens up about his challenges and shares some key advice for the institution’s next leader.

Business

Stephen Tang to Step Down as Science Center CEO

His ten-year term completely transformed the University City institution and Philadelphia at large.

Business

10 Things to Know About Philly New Tech Meetup’s Executive Director

Darla Wolfe now leads the group that claims more than 5,000 members.

Business

The $850K, Philly-Developed Blindness Treatment That Could Be the Gateway to Curing Big Disease

Spark Therapeutics’s new drug may be worth every cent.